Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on Equity

Intelligent Bio Solutions (INBS) EBITDA Margin (2019 - 2025)

Intelligent Bio Solutions has reported EBITDA Margin over the past 6 years, most recently at 378.94% for Q1 2024.

  • For Q1 2024, EBITDA Margin rose 102784.0% year-over-year to 378.94%; the TTM value through Mar 2024 reached 355.87%, up 6860.0%, while the annual FY2023 figure was 828.97%, 28807.0% down from the prior year.
  • EBITDA Margin for Q1 2024 was 378.94% at Intelligent Bio Solutions, down from 248.83% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 18.36% in Q4 2022 and troughed at 9885.81% in Q1 2021.
  • A 5-year average of 1349.3% and a median of 638.38% in 2020 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: surged 21283192bps in 2020 and later crashed -800558bps in 2021.
  • Year by year, EBITDA Margin stood at 691.26% in 2020, then plummeted by -181bps to 1944.12% in 2021, then surged by 99bps to 18.36% in 2022, then plummeted by -1256bps to 248.83% in 2023, then tumbled by -52bps to 378.94% in 2024.
  • Business Quant data shows EBITDA Margin for INBS at 378.94% in Q1 2024, 248.83% in Q4 2023, and 306.9% in Q3 2023.